Home ›
Trademark Categories ›
Pharmaceuticals ›
2007 ›
SI ›
SITAMYC
Trademark search for:
SITAMYC
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2007-12-10 — Application filed
2007-12-13 — Application filed
2008-02-23 — Final disposition recorded
2008-02-23 — Final disposition recorded
2008-02-23 — Assigned to examiner
2008-02-23 — Final disposition recorded
2008-07-10 — Teas/email correspondence entered
2008-07-10 — Office action issued
2008-07-10 — Correspondence received in law office
2008-07-14 — Suspension letter written
2008-07-14 — Letter of suspension e-mailed
2008-07-14 — Notification of letter of suspension e-mailed
2009-01-14 — Report completed suspension check case still suspended
2009-01-14 — Assigned to lie
2009-07-14 — Report completed suspension check case still suspended
2010-01-15 — Report completed suspension check case still suspended
2010-07-16 — Report completed suspension check case still suspended
2011-01-19 — Suspension checked - to attorney for action
2011-01-21 — Final disposition recorded
2011-01-21 — Final disposition recorded
2011-01-21 — Final disposition recorded
2011-01-21 — Final disposition recorded
2011-01-21 — Final disposition recorded
2011-01-21 — Final disposition recorded
2011-09-02 — Application abandoned
2011-09-02 — Final status recorded
2011-09-06 — Application abandoned
Owner Information
BIOALLIANCE PHARMA S.A.
Paris FR
Correspondent
DEAN R. KARAU FREDRIKSON & BYRON, P.A. 200 S 6TH ST STE 4000 MINNEAPOLIS, MN 55402-1425 UNITED STATES
Filing Details
Filing Date:
2007-12-10
Status Date:
2011-09-02
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.